Search - tctmd.com

Displaying 1 - 20 of 488

Sort: Relevancy | Date

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

L.A. McKeown

March 17, 2026

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Conference News STS 2026

New TAVI Explant Risk Model Reflects Growing Experience

Yael L. Maxwell

January 30, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Advertisement

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

What’s Going to Be Hot at ACC 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

Experience Matters as Ross Procedure Gains Popularity in North America

TCTMD’s Top 10 Most Popular Stories for February 2026

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

New TAVI Explant Risk Model Reflects Growing Experience

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

TCTMD’s Biggest News of 2025

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

TCTMD’s Top 10 Most Popular Stories for December 2025

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Frail Patients Stand to Gain Most From Cardiac Rehab

What’s Going to Be Hot at AHA 2025?

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content